Literature DB >> 1378830

Growth of a human yolk sac tumor cell line with yolk sac-derived functions in selenium-supplemented chemically defined synthetic medium.

K Ohkawa1, T Hatano, N Takizawa, K Shinmoto, K Yamada, M Matsuda, K Takada, Y Tsukada.   

Abstract

A human yolk sac tumor cell line, TG1, which was established from a testicular yolk sac tumor, was found to replicate continuously in a chemically defined medium supplemented with Na2SeO3 (ISRPMI). TG1 produced several plasma proteins and growth factors: albumin, alpha-fetoprotein (AFP), ferritin, carcinoembryonic antigen, beta-2-microglobulin, polyamine, neuron specific enolase, tissue polypeptide antigen, transferrin (Tf), epidermal growth factor, and platelet derived growth factor. By analysis of lentil lectin (LcHA)-affinity electrophoresis, to examine the microheterogeneity of carbohydrate chains of synthetic glycoproteins, TG1 cells cultured with ISRPMI produced only LcHA reactive Tf and AFP based on core fucose attached to asparagine-linked N-acetylglucosamine residues instead of LcHA-nonreactive Tf and AFP produced by TG1 cells cultured with fetal bovine serum (FBS)-containing medium. alpha 1-6 Fucosyltransferase activity was significantly greater in the TG1 cells cultured with ISRPMI (39.9 +/- 1.5 pmol.h-1.mg-1 protein) than cultured with FBS-containing media (18.2 +/- 1.2 pmol.h-1.mg-1 protein). These results have indicated that the selective increase of alpha 1-6 fucosyltransferase occurred when the cells were cultured with the FBS-free synthetic media.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378830     DOI: 10.1007/bf02634050

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  25 in total

1.  A quantitative method for GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha 1----6fucosyltransferase activity with lectin affinity chromatography.

Authors:  J A Voynow; T F Scanlin; M C Glick
Journal:  Anal Biochem       Date:  1988-02-01       Impact factor: 3.365

2.  Plasma protein and apolipoprotein synthesis by human yolk sac carcinoma cells in vitro.

Authors:  R E Lanford; D L Bronson; L E Estlack; F H Wians
Journal:  In Vitro Cell Dev Biol       Date:  1991-03

3.  Further resolution of human alpha-fetoprotein by affinity electrophoresis with erythroagglutinating phytohemagglutinin of Phaseolus vulgaris lectin.

Authors:  K Taketa; E Ichikawa; H Nakabayashi; J Sato; K Kato; S Akai; R Ohkawa; K Ohkawa; H Taga; H Hirai
Journal:  Tumour Biol       Date:  1985

4.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Clear cell carcinoma of the human ovary synthesizes and secretes a transferrin with microheterogeneity of lectin affinity.

Authors:  K Ohkawa; K Takada; N Takizawa; T Hatano; Y Tsukada; M Matsuda
Journal:  FEBS Lett       Date:  1990-09-17       Impact factor: 4.124

7.  A new serum-free method of measuring growth factor activities for human breast cancer cells in culture.

Authors:  M Ogasawara; D A Sirbasku
Journal:  In Vitro Cell Dev Biol       Date:  1988-09

8.  Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma.

Authors:  K Yamashita; N Koide; T Endo; Y Iwaki; A Kobata
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

9.  Establishment and characterization of a human ovarian endodermal sinus tumor cell line--producing specific type of alpha-fetoprotein subfraction.

Authors:  I Ishiwata; T Ishiguro; C Ishiwata; M Soma; H Ishikawa
Journal:  Gynecol Oncol       Date:  1986-11       Impact factor: 5.482

10.  Human yolk sac tumor serially transplanted in nude mice: its morphologic and functional properties.

Authors:  J I Hata; Y Ueyama; N Tamaoki; A Akatsuka; S Yoshimura; K Shimuzu; Y Morikawa; T Furukawa
Journal:  Cancer       Date:  1980-12-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.